Study Overview: This study looks at the safety of CG-P5 peptide eye drops for people with a condition called age-related wet macular degeneration (*wAMD*). This condition affects the eye and can cause vision problems. The study will compare the eye drops to a placebo, which looks like the real medicine but doesn’t have any active ingredients.
- Duration and Visits: You will need to visit the clinic multiple times during the study.
- Eligibility: You must be 50 years or older, have wAMD, and meet other health requirements.
- Risks and Benefits: There might be some risks, and you should discuss these with the study team.
Who Can Join: Both men and women over 50 years old with wAMD may participate if they meet certain health conditions. It's important you can follow the study instructions and visit the clinic as needed.
Who Cannot Join: If you have other serious eye problems, recent eye surgery, or certain health conditions like uncontrolled diabetes or high blood pressure, you might not be able to participate. Talk to the study team to see if you qualify.